PMC:6365940 / 1400-1735 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/6365940","sourcedb":"PMC","sourceid":"6365940","source_url":"https://www.ncbi.nlm.nih.gov/pmc/6365940","text":"• Digoxin could reverse drug resistance of gemcitabine in gemcitabine-resistant pancreatic cancer cells.\n• Digoxin significantly inhibited Nrf2 signaling in gemcitabine-resistant pancreatic cancer cells.\n• Digoxin-mediated reversing drug resistance of gemcitabine in gemcitabine-resistant pancreatic cancer cells was Nrf2 dependent.","divisions":[{"label":"label","span":{"begin":0,"end":1}},{"label":"p","span":{"begin":3,"end":105}},{"label":"label","span":{"begin":106,"end":107}},{"label":"p","span":{"begin":109,"end":205}},{"label":"label","span":{"begin":206,"end":207}}],"tracks":[]}